Second-line treatment of PD-1 and CTLA-4 blockade combined with liposomal irinotecan plus leucovorin and fluorouracil for advanced cholangiocarcinoma: study protocol of a single-arm, prospective phase II trial
This study protocol and amendments have been approved by the Ethics Committee of West China Hospital (2024(791)).
Authors
- Xiaofen Li
- Linjuan Li
- Dan Cao (ORCID: https://orcid.org/0000-0003-2755-7258)
- Yuhang Ma (ORCID: https://orcid.org/0009-0004-0570-2949)
- Yang Yu
- Heqi Yang (ORCID: https://orcid.org/0000-0003-3165-2098)
Institutions
- Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1177/17588359241292264
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57